Document
Academic Article
Generically Dependent Continuant
RDF description of Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: A double-blind, randomised, phase 3 study - http://irises.unibs.it/resource/item/52032
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: A double-blind, randomised, phase 3 study
Article
Information Content Entity